$KALA one penny that i like a lot at current levels. When it comes to small bio names catching a falling knife carries tremendous risk although risk takers can be rewarded with sizeable gains. The stock has shown significant improvement in its stock performance recently, largely tied to the involvement of David E. Lazar. He has a proven track record in these plays. Lazar's entry provided lifeline capital, stabilized the company, and sparked speculative trading on turnaround/reverse merger potential. At current levels the bottom looks to be in and the risk of more bloodshed is a lot lower than it was weeks, or even days ago. Lets keep an eye on her. A break of 73c could send it to +$1 imho